Rezultaty - GRABSCH, HEIKE
- Rezultaty 1 - 20 Rezultaty od 60
- Idź do następnej strony
-
1
-
2
-
3
-
4
Histopathological Features in Colonic Biopsies at Diagnosis Predict Long-term Disease Course in Patients with Crohn’s Disease od Rezazadeh Ardabili, Ashkan, Goudkade, Danny, Wintjens, Dion, Romberg-Camps, Mariëlle, Winkens, Bjorn, Pierik, Marie, Grabsch, Heike I, Jonkers, Daisy
Wydane 2021Text -
5
Immunophenotypes of pancreatic ductal adenocarcinoma: Meta‐analysis of transcriptional subtypes od de Santiago, Ines, Yau, Christopher, Heij, Lara, Middleton, Mark R., Markowetz, Florian, Grabsch, Heike I., Dustin, Michael L., Sivakumar, Shivan
Wydane 2019Text -
6
Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review od Draht, Muriel X. G., Goudkade, Danny, Koch, Alexander, Grabsch, Heike I., Weijenberg, Matty P., van Engeland, Manon, Melotte, Veerle, Smits, Kim M.
Wydane 2018Text -
7
Hypothesis‐free deep survival learning applied to the tumour microenvironment in gastric cancer od Meier, Armin, Nekolla, Katharina, Hewitt, Lindsay C, Earle, Sophie, Yoshikawa, Takaki, Oshima, Takashi, Miyagi, Yohei, Huss, Ralf, Schmidt, Günter, Grabsch, Heike I
Wydane 2020Text -
8
Identification of a high‐risk subtype of intestinal‐type Japanese gastric cancer by quantitative measurement of the luminal tumor proportion od Aoyama, Toru, Hutchins, Gordon, Arai, Tomio, Sakamaki, Kentaro, Miyagi, Yohei, Tsuburaya, Akira, Ogata, Takashi, Oshima, Takashi, Earle, Sophie, Yoshikawa, Takaki, Grabsch, Heike I.
Wydane 2018Text -
9
Gastric cancer biomarker analysis in patients treated with different adjuvant chemotherapy regimens within SAMIT, a phase III randomized controlled trial od Oshima, Takashi, Tsuburaya, Akira, Yoshida, Kazuhiro, Yoshikawa, Takaki, Miyagi, Yohei, Rino, Yasushi, Masuda, Munetaka, Guan, Jia, Tan, Patrick, Grabsch, Heike I., Sakamoto, Junichi, Tanaka, Shiro
Wydane 2022Text -
10
Five biopsy specimens from the proximal part of the tumor reliably determine HER2 protein expression status in gastric cancer od Tominaga, Naoyuki, Gotoda, Takuji, Hara, Megumi, Hale, Matthew D., Tsuchiya, Takayoshi, Matsubayashi, Jun, Kono, Shin, Kusano, Chika, Itoi, Takao, Fujimoto, Kazuma, Moriyasu, Fuminori, Grabsch, Heike I.
Wydane 2015Text -
11
High resolution analysis of DNA copy-number aberrations of chromosomes 8, 13, and 20 in gastric cancers od Buffart, Tineke E., van Grieken, Nicole C. T., Tijssen, Marianne, Coffa, Jordy, Ylstra, Bauke, Grabsch, Heike I., van de Velde, Cornelis J. H., Carvalho, Beatriz, Meijer, Gerrit A.
Wydane 2009Text -
12
Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy – results from the MRC OE02 oesophageal cancer trial od Davarzani, Nasser, Hutchins, Gordon G A, West, Nicholas P, Hewitt, Lindsay C, Nankivell, Matthew, Cunningham, David, Allum, William H, Smyth, Elizabeth, Valeri, Nicola, Langley, Ruth E, Grabsch, Heike I
Wydane 2018Text -
13
Histological intratumoral heterogeneity in pretreatment esophageal cancer biopsies predicts survival benefit from neoadjuvant chemotherapy: results from the UK MRC OE02 trial od Davarzani, Naser, Hewitt, Lindsay C, Hale, Matthew D, Melotte, Veerle, Nankivell, Matthew, Hutchins, Gordon G A, Cunningham, David, Allum, William H, Langley, Ruth E, Jolani, Shahab, Grabsch, Heike I
Wydane 2020Text -
14
KRAS status is related to histological phenotype in gastric cancer: results from a large multicentre study od Hewitt, Lindsay C., Saito, Yuichi, Wang, Tan, Matsuda, Yoko, Oosting, Jan, Silva, Arnaldo N. S., Slaney, Hayley L., Melotte, Veerle, Hutchins, Gordon, Tan, Patrick, Yoshikawa, Takaki, Arai, Tomio, Grabsch, Heike I.
Wydane 2019Text -
15
Correction to: KRAS status is related to histological phenotype in gastric cancer: results from a large multicentre study od Hewitt, Lindsay C., Saito, Yuichi, Wang, Tan, Matsuda, Yoko, Oosting, Jan, Silva, Arnaldo N. S., Slaney, Hayley L., Melotte, Veerle, Hutchins, Gordon, Tan, Patrick, Yoshikawa, Takaki, Arai, Tomio, Grabsch, Heike I.
Wydane 2019Text -
16
Expression of proteins associated with the Warburg‐effect and survival in colorectal cancer od Offermans, Kelly, Jenniskens, Josien CA, Simons, Colinda CJM, Samarska, Iryna, Fazzi, Gregorio E, Smits, Kim M, Schouten, Leo J, Weijenberg, Matty P, Grabsch, Heike I, van den Brandt, Piet A
Wydane 2021Text -
17
Predicting Mutational Status of Driver and Suppressor Genes Directly from Histopathology With Deep Learning: A Systematic Study Across 23 Solid Tumor Types od Loeffler, Chiara Maria Lavinia, Gaisa, Nadine T., Muti, Hannah Sophie, van Treeck, Marko, Echle, Amelie, Ghaffari Laleh, Narmin, Trautwein, Christian, Heij, Lara R., Grabsch, Heike I., Ortiz Bruechle, Nadina, Kather, Jakob Nikolas
Wydane 2022Text -
18
Gastric cancers of Western European and African patients show different patterns of genomic instability od Buffart, Tineke E, Louw, Melanie, van Grieken, Nicole CT, Tijssen, Marianne, Carvalho, Beatriz, Ylstra, Bauke, Grabsch, Heike, Mulder, Chris JJ, van de Velde, Cornelis JH, van der Merwe, Schalk W, Meijer, Gerrit A
Wydane 2011Text -
19
Epidemiological, clinical and endoscopic characteristics of colorectal neuroendocrine neoplasms: a population-based study in the Netherlands od Reumkens, Ankie, Sastrowijoto, Prapto, Grabsch, Heike I., Goudkade, Danny, le Clercq, Chantal, Bakker, Minke, Keulen, Eric, de Ridder, Rogier, de Herder, Wouter W., Winkens, Bjorn, Sanduleanu, Silvia, de Vos-Geelen, Judith, Masclee, Ad
Wydane 2022Text -
20
Energy balance‐related factors in childhood and adolescence and risk of colorectal cancer expressing different levels of proteins involved in the Warburg‐effect od Jenniskens, Josien C. A., Offermans, Kelly, Simons, Colinda C. J. M., Samarska, Iryna, Fazzi, Gregorio E., Smits, Kim M., Schouten, Leo J., Weijenberg, Matty P., Grabsch, Heike I., van den Brandt, Piet A.
Wydane 2022Text